Trial intelligence / Profile preview

TIME: Timing of ART Initiation in HIV/TB Co-infection

NCT01014481Phase 4Terminated

Sponsor
Bamrasnaradura Infectious Diseases Institute
Start
Oct 2009
Primary completion
May 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tenofovir, lamivudine, efavirenz in human immunodeficiency virus infection (HIV), sponsored by Bamrasnaradura Infectious Diseases Institute. Started Oct 2009; status: terminated.

02

Drugs

tenofovirlamivudineefavirenz
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT01014481.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01014481.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call